Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.4217
+0.0021 (0.50%)
Oct 13, 2025, 4:00 PM EDT - Market closed
HBIO's stock price has decreased by -83.33% in the past year and price targets may not have had time to catch up.
Harvard Bioscience Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$2.50
Upside
+492.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +374.27% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $4.5 → $3 | Buy | Maintains | $4.5 → $3 | +611.41% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +967.11% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,559.95% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +1,559.95% | Apr 26, 2023 |
| Keybanc | Keybanc | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +1,559.95% | Apr 26, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +848.54% | Mar 10, 2023 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +1,085.68% | Nov 9, 2022 |
| Keybanc | Keybanc | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +1,559.95% | Aug 5, 2022 |
| Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +1,322.81% | Nov 10, 2020 |
| Benchmark | Benchmark | Buy Maintains $3.5 → $4 | Buy | Maintains | $3.5 → $4 | +848.54% | Feb 27, 2020 |
| Benchmark | Benchmark | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,797.08% | Jul 28, 2015 |